169 related articles for article (PubMed ID: 19391334)
1. [Integrated multidisciplinary treatment of colorectal neoplasms].
Procacciante F; Caciolo F; Diamantini G; Flati D; Pitasi F; Abilaliaj V; Covotta A; Banelli E; Di Seri M; Citone G
Chir Ital; 2009; 61(1):1-10. PubMed ID: 19391334
[TBL] [Abstract][Full Text] [Related]
2. [Colorectal carcinoma].
Schulthess G; Kolyvanos Naumann U; Käser L; Vetter W
Praxis (Bern 1994); 2005 Nov; 94(44):1705-11; quiz 1712. PubMed ID: 16309014
[No Abstract] [Full Text] [Related]
3. [Four cases of locally advanced colorectal cancer resected successfully after preoperative chemotherapy].
Yoneda A; Okada K; Matsuo M; Kajiyama M; Kishikawa H
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1699-703. PubMed ID: 21996971
[TBL] [Abstract][Full Text] [Related]
4. [Colorectal cancer: what should be the management of primary tumour?].
Lelong B; Moutardier V; Delpero JR
Rev Prat; 2004 Jan; 54(2):155-66. PubMed ID: 15086058
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].
Medinger M; Steinbild S; Mross K
Praxis (Bern 1994); 2004 Sep; 93(40):1633-44. PubMed ID: 15495753
[TBL] [Abstract][Full Text] [Related]
6. Current status of adjuvant therapy for colorectal cancer.
O'Connell MJ
Oncology (Williston Park); 2004 May; 18(6):751-5; discussion 755-8. PubMed ID: 15214594
[TBL] [Abstract][Full Text] [Related]
7. Treatment of colorectal cancer.
Påhlman L
Ann Chir Gynaecol; 2000; 89(3):216-20. PubMed ID: 11079791
[No Abstract] [Full Text] [Related]
8. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
9. Surgical adjuvant therapy for colorectal cancer: current approaches and future directions.
Monga DK; O'Connell MJ
Ann Surg Oncol; 2006 Aug; 13(8):1021-34. PubMed ID: 16897272
[TBL] [Abstract][Full Text] [Related]
10. [Colorectal carcinoma--approval of eloxatine in adjuvant therapy--better chances for recovery].
Krankenpfl J; 2004; 42(7-10):234. PubMed ID: 15675396
[No Abstract] [Full Text] [Related]
11. [Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials].
Lamberti C; Lundin S; Bogdanow M; Gorschlüter M; Schmidt-Wolf IG; Sauerbruch T
Dtsch Med Wochenschr; 2006 Mar; 131(10):485-90. PubMed ID: 16511737
[TBL] [Abstract][Full Text] [Related]
12. Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.
Hegewisch-Becker S; Graeven U; Lerchenmüller CA; Killing B; Depenbusch R; Steffens CC; Al-Batran SE; Lange T; Dietrich G; Stoehlmacher J; Tannapfel A; Reinacher-Schick A; Quidde J; Trarbach T; Hinke A; Schmoll HJ; Arnold D
Lancet Oncol; 2015 Oct; 16(13):1355-69. PubMed ID: 26361971
[TBL] [Abstract][Full Text] [Related]
13. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis.
Kim MS; Chung M; Ahn JB; Kim CW; Cho MS; Shin SJ; Baek SJ; Hur H; Min BS; Baik SH; Kim NK
J Surg Oncol; 2014 Aug; 110(2):214-21. PubMed ID: 24668581
[TBL] [Abstract][Full Text] [Related]
15. Multi-modality therapy for metastatic colorectal cancer-ready for prime time?
Chua TC; Marshall JL; Marshall MB; Esquivel J
Am Surg; 2010 Jul; 76(7):777-8. PubMed ID: 20698392
[No Abstract] [Full Text] [Related]
16. Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer.
Angitapalli R; Litwin AM; Kumar PR; Nasser E; Lombardo J; Mashtare T; Wilding GE; Fakih MG
Oncology; 2009; 76(5):363-8. PubMed ID: 19321964
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies.
Ohtani H; Arimoto Y; Nishio K; Kanamiya Y; Oba H; Adachi K; Shintani M; Nakamura R; Yui S
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1769-74. PubMed ID: 18931586
[TBL] [Abstract][Full Text] [Related]
18. Treatment patterns and metastasectomy among mCRC patients receiving chemotherapy and biologics.
Song X; Zhao Z; Barber B; Gregory C; Wang PF; Long SR
Curr Med Res Opin; 2011 Jan; 27(1):123-30. PubMed ID: 21128878
[TBL] [Abstract][Full Text] [Related]
19. Downstaging without complete pathologic response after neoadjuvant treatment improves cancer outcomes for cIII but not cII rectal cancers.
de Campos-Lobato LF; Stocchi L; da Luz Moreira A; Kalady MF; Geisler D; Dietz D; Lavery IC; Remzi FH; Fazio VW
Ann Surg Oncol; 2010 Jul; 17(7):1758-66. PubMed ID: 20131015
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.
Chang MH; Lee IK; Si Y; Lee KS; Woo IS; Byun JH
Cancer Chemother Pharmacol; 2011 Aug; 68(2):317-23. PubMed ID: 20972872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]